NCT06185920 PHAGEinLYON Clinic Cohort Study: a Descriptive Study of Severe Infections Treated With Phage Therapy at the HCL.
| NCT ID | NCT06185920 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Hospices Civils de Lyon |
| Condition | Severe Infection |
| Study Type | OBSERVATIONAL |
| Enrollment | 250 participants |
| Start Date | 2023-02-01 |
| Primary Completion | 2033-02-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 250 participants in total. It began in 2023-02-01 with a primary completion date of 2033-02-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
PHAGEinLYON Clinic cohort study is a single site non-interventional retrospective and prospective study, initiated by the Hospices Civils de Lyon. Population targeted are patients with a severe infection treated with bacteriophage in the Hospices civils de Lyon from 2015 to 2033. The primary objective is to describe the severe infections treated with phagotherapy. 250 patients will be included in the study.
Eligibility Criteria
Inclusion Criteria: * Patient with severe infection treated with bacteriophage in the Hospices Civils de Lyon from 01/01/2015 to 01/01/2033 * PHAGEinLYON Clinic cohort study information notice provided to the patient Exclusion Criteria: * Opposition of trial participant
Frequently Asked Questions
Who can join the NCT06185920 clinical trial?
This trial is open to participants of all sexes, studying Severe Infection. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06185920 currently recruiting?
Yes, NCT06185920 is actively recruiting participants. Visit ClinicalTrials.gov or contact Hospices Civils de Lyon to inquire about joining.
Where is the NCT06185920 trial being conducted?
This trial is being conducted at Lyon, France.
Who is sponsoring the NCT06185920 clinical trial?
NCT06185920 is sponsored by Hospices Civils de Lyon. The trial plans to enroll 250 participants.